# Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers

> **NCT06958224** · NA · NOT_YET_RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 360 (estimated)

## Conditions studied

- Breast Cancer
- Liver Cancer
- Pancreatic Ductal Adenocarcinoma

## Interventions

- **GENETIC:** Large and early multigene sequencing

## Key facts

- **NCT ID:** NCT06958224
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2028-11-10
- **Final completion:** 2029-01-09
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06958224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06958224, "Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06958224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*